C. Curti et al. / European Journal of Medicinal Chemistry 42 (2007) 880e884
883
5.1.1.2. 1-(4-Nitrophenyl)-2-(toluene-4-sulfonyl)-ethanone 3b.
J ¼ 8.9 Hz, 2H), 8.19 (d, J ¼ 7.3 Hz, 1H), 8.17 (d,
J ¼ 8.2 Hz, 1H), 8.05 (d, J ¼ 8.9 Hz, 2H), 7.99 (m, 1H), 7.73
(m, 2H), 7.56 (t, J ¼ 7.7 Hz, 1H), 4.94 (s, 2H). 13C NMR
(CDCl3), d: 63.4 (CH2), 123.5 (CH), 123.9 (2CH), 124.3
(CH), 127.4 (CH), 128.7 (CH), 129.3 (C), 129.4 (CH), 130.3
(2CH), 131.4 (CH), 133.5 (C), 134.2 (C), 136.2 (CH), 140.1
(C), 186.8 (C]O). CeNO2 not observed in these conditions.
Anal. Calcd for C18H13NO5S (355.37): C, 60.84; H, 3.69; N,
3.94. Found: C, 60.46; H, 3.49; N, 4.10.
Pale yellow crystals, m.p. 147 ꢀC (CH2Cl2/hexane) (Lit.:
1
146e147 ꢀC [24]), H NMR (CDCl3), d: 8.34 (d, J ¼ 9.0 Hz,
2H), 8.15 (d, J ¼ 9.0 Hz, 2H), 7.75 (d, J ¼ 7.9 Hz, 2H), 7.37
(d, J ¼ 7.9 Hz, 2H), 4.74 (s, 2H), 2.47 (s, 3H). 13C NMR
(CDCl3), d: 21.7 (CH3), 64.2 (CH2), 124.0 (2CH), 128.5
(2CH), 130.0 (2CH), 130.5 (2CH), 135.4 (C), 140.0 (C),
145.9 (C), 187.0 (C]O), CeNO2 not observed in these con-
ditions. Anal. Calcd for C15H13NO5S (319.33): C, 56.42; H,
4.10; N, 4.39. Found: C, 56.23; H, 4.06; N, 4.17.
5.1.2. General procedure for the preparation of 4a and b
To a solution of 2-benzenesulfonyl-1-(4-nitrophenyl)-etha-
none (0.500 g, 1.63 mmol) in DMSO (15 mL) under inert at-
mosphere, NaH (0.043 g, 1.8 mmol) was added. The reaction
mixture was stirred for 1.5 h and then alkyl halide
(1.8 mmol) in DMSO (2 mL) was added. After completion
of the reaction (TLC), it was diluted with cold water and the
solid precipitate was filtered and purified by flash column
chromatography (eluent: toluene for 4a, petroleum ether/ace-
tone (6:4) for 4b).
5.1.1.3. 2-(4-Nitrobenzenesulfonyl)-1-(4-nitrophenyl)-ethanone
3c. Yellow crystals, m.p. 188 ꢀC (ethanol) (Lit.: 190e192 ꢀC
1
[24]), H NMR (CDCl3), d: 8.45 (d, J ¼ 9.0 Hz, 2H), 8.38 (d,
J ¼ 9.0 Hz, 2H), 8.14 (m, 4H), 4.84 (s, 2H). 13C NMR
(CDCl3), d: 63.4 (CH2), 124.2 (2CH), 124.5 (2CH), 130.3
(2CH), 130.4 (2CH), 139.5 (C), 143.6 (C), 186.5 (C]O),
CeNO2 not observed in these conditions. Anal. Calcd for
C14H10N2O7S (350.30): C, 48.00; H, 2.88; N, 8.00. Found:
C, 48.21; H, 3.05; N, 8.09.
5.1.1.4. 2-(4-Fluorobenzenesulfonyl)-1-(4-nitrophenyl)-etha-
none 3d. Colorless crystals, m.p. 139e140 ꢀC (CH2Cl2/hex-
ane, 3:7), 1H NMR (CDCl3), d: 8.36 (d, J ¼ 9.0 Hz, 2H), 8.16
(d, J ¼ 9.0 Hz, 2H), 7.90 (dd, J ¼ 1.4, 4.9 Hz, 2H), 7.26 (d,
2H), 4.77 (s, 2H). 13C NMR (CDCl3), d: 63.9 (CH2), 116.8
(d, J ¼ 23.0 Hz, 2CH), 124.0 (2CH), 130.4 (2CH), 131.6 (d,
J ¼ 9.9 Hz, 2CH), 134.3 (d, J ¼ 3.3 Hz, C), 139.8 (C), 151.0
(C), 166.3 (d, J ¼ 258.3 Hz, C), 186.9 (C]O), CeNO2 not
observed in these conditions. Anal. Calcd for C14H10FNO5S
(355.37): C, 52.01; H, 3.12; N, 4.33. Found: C, 52.11; H,
3.19; N, 4.29.
5.1.2.1. 2-Benzenesulfonyl-1-(4-nitrophenyl)-3-phenyl-propan-
1-one 4a. Buff crystals, m.p. 171 ꢀC (diethyl ether), 1H
NMR (CDCl3), d: 8.19 (d, J ¼ 9.0 Hz, 2H), 7.84 (m, 4H),
7.73 (m, 1H), 7.60 (m, 3H), 7.14 (m, 3H), 7.05 (m, 1H),
5.28 (m, 1H), 3.39 (m, 2H). 13C NMR (CDCl3), d: 34.2
(CH2), 72.5 (CH), 123.8 (2CH), 127.4 (CH), 128.8 (2CH),
129.0 (2CH), 129.2 (2CH), 129.6 (2CH), 129.8 (2CH), 134.7
(CH), 135.3 (C), 136.1 (C), 141.6 (CH), 150.5 (C), 191.5
(C]O). Anal. Calcd for C21H17NO5S (395.43): C, 63.79; H,
4.33; N, 3.54. Found: C, 63.93; H, 4.38; N, 3.42.
5.1.2.2. 2-Benzenesulfonyl-3-imidazo[1,2-a]pyrazin-2-yl-1-(4-
5.1.1.5. 2-(4-Chlorobenzenesulfonyl)-1-(4-nitrophenyl)-etha-
none 3e. Yellow crystals, m.p. 150 ꢀC (CH2Cl2/hexane)
(Lit.: 156e157 ꢀC [24]), 1H NMR spectrum (CDCl3), d:
8.36 (d, J ¼ 9.0 Hz, 2H), 8.16 (d, J ¼ 9.0 Hz, 2H), 7.82 (d,
J ¼ 8.9 Hz, 2H), 7.56 (d, J ¼ 8.9 Hz, 2H), 4.77 (s, 2H). 13C
NMR spectrum (CDCl3), d: 63.8 (CH2), 124.1 (2CH), 129.8
(2CH), 130.1 (2CH), 130.5 (2CH), 136.7 (C), 139.8 (C),
141.6 (C), 151.0 (CeNO2), 186.8 (C]O). Anal. Calcd for
C14H10ClNO5S (339.75): C, 49.49; H, 2.97; N, 4.12. Found:
C, 49.80; H, 3.12; N, 3.93.
nitrophenyl)-propan-1-one 4b. Colorless crystals, m.p. 156e
1
157 ꢀC (butan-2-ol), H NMR (CDCl3), d: 8.81 (s, 1H), 8.26
(d, J ¼ 9.0 Hz, 2H), 8.12 (d, J ¼ 9.0 Hz, 2H), 7.94 (dd,
J ¼ 1.3, 4.5 Hz, 1H), 7.82 (m, 3H), 7.65 (d, J ¼ 7.3 Hz, 1H),
7.53 (m, 3H), 5.99 (m, 1H), 3.68 (m, 2H). 13C NMR
(CDCl3), d: 26.9 (CH2), 69.2 (CH), 111.4 (CH), 118.5 (CH),
123.7 (2CH), 129.3 (2CH), 129.5 (2CH), 129.9 (CH), 130.1
(2CH), 134.7 (CH), 136.5 (C), 141.5 (C), 142.8 (CH), 143.4
(C), 191.1 (C]O). CeNO2 not observed in these conditions.
Anal. Calcd for C21H16N4O5S (436.44): C, 57.79; H, 3.70; N,
12.84. Found: C, 57.96; H, 3.73; N, 12.37.
5.1.1.6. 2-(4-Iodobenzenesulfonyl)-1-(4-nitrophenyl)-ethanone
3f. Yellow crystals, m.p. 209e210 ꢀC (cyclohexane) (Lit.:
1
217 ꢀC [24]), H NMR (DMSO-d6), d: 8.31 (d, J ¼ 8.6 Hz,
5.2. Antimicrobial activity
2H), 8.16 (d, J ¼ 8.6 Hz, 2H), 8.02 (d, J ¼ 8.1 Hz, 2H), 7.64
(d, J ¼ 8.1 Hz, 2H), 5.50 (s, 2H). 13C NMR (DMSO-d6), d:
62.7 (CH2), 103.2 (C), 123.9 (2CH), 129.9 (2CH), 130.6
(2CH), 138.3 (2CH), 138.9 (C), 140.2 (C), 150.5 (C), 188.7
(C]O). Anal. Calcd for C14H10INO5S (431.20): C, 39.00;
H, 2.34; N, 3.25. Found: C, 38.89; H, 2.10; N, 3.23.
5.2.1. Microorganisms and media
Six reference strains were used in our study.
Escherichia coli ATCC 10536.
Pseudomonas aeruginosa ATCC 15442.
Staphylococcus aureus ATCC 6538.
Enterococcus hirae ATCC 10541.
Candida albicans ATCC 90029.
Candida tropicalis IP 2031.
5.1.1.7. 2-(Naphthalene-1-sulfonyl)-1-(4-nitrophenyl)-ethanone
1
3g. Buff crystals, m.p. 169e170 ꢀC (CH2Cl2/hexane, 1:9), H
NMR (CDCl3), d: 8.76 (d, J ¼ 8.5 Hz, 1H), 8.26 (d,